1. Home
  2. ACNB vs DCTH Comparison

ACNB vs DCTH Comparison

Compare ACNB & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACNB Corporation

ACNB

ACNB Corporation

N/A

Current Price

$66.76

Market Cap

659.3M

Sector

Finance

ML Signal

N/A

DCTH

Delcath Systems Inc.

N/A

Current Price

$20.63

Market Cap

578.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACNB
DCTH
Founded
1857
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
659.3M
578.4M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
ACNB
DCTH
Price
$66.76
$20.63
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
★ $70.33
$28.60
AVG Volume (30 Days)
44.8K
★ 653.4K
Earning Date
10-22-2026
11-09-2026
Dividend Yield
★ 2.51%
N/A
EPS Growth
N/A
★ 107.53
EPS
★ 4.36
0.21
Revenue
★ $191,821,000.00
N/A
Revenue This Year
$11.18
$36.66
Revenue Next Year
$2.76
$20.12
P/E Ratio
★ $15.28
$101.90
Revenue Growth
★ 45.10
N/A
52 Week Low
$44.62
$8.12
52 Week High
$68.85
$22.51

Technical Indicators

Market Signals
Indicator
ACNB
DCTH
Relative Strength Index (RSI) 59.80 72.77
Support Level $62.14 $10.76
Resistance Level $68.23 N/A
Average True Range (ATR) 1.42 1.10
MACD 0.07 0.81
Stochastic Oscillator 53.71 79.30

Price Performance

Historical Comparison
ACNB
DCTH

About ACNB ACNB Corporation

ACNB Corp is the financial holding company. Through its wholly-owned subsidiaries, it provides a full range of retail and commercial financial services in Pennsylvania and Maryland through its network of community banking offices. It also provides property, casualty, health, life and disability insurance serving personal and commercial clients through offices in Westminster, Maryland, and Gettysburg, Pennsylvania and is licensed to do business. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage; and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: